Ernesto M. Nogueira
Managing Director
Value Connected, Netherlands
Mattias Kyhlstedt
CEO
Synergus AB, Denmark
Planning for a global product launch means a coherent evidence plan and value dossier must address the needs of multiple geographies. This session will review the evolving perspectives of US payers on evidence for medical devices, and contrast these trends with major EU markets and Japan. Specific topics to be addressed will include:
Stephen Hull
Principal and Founder
Hull Associates, USA